Social media

ICON has done it again! For the third consecutive year, we’ve been named one of TIME and Statista’s World’s Best Companies of 2025. This honour celebrates our people, our purpose, and our progress. Thank you to everyone ...

We’re proud to share that ICON has been named one of TIME and Statista’s World’s Best Companies of 2025 — for the third year in a row! This recognition reflects our continued commitment to innovation, growth, employee s...

Missed our recent webinar on advancing clinical trials in neurodegenerative diseases? If you were unable to attend Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases, the fu...

Smarter monitoring drives better trial delivery. ICON’s whitepaper explores how evolving Clinical Research Associate roles are improving efficiency, oversight and site engagement. Read more: https://www.iconplc.com/in...

Smarter monitoring drives better trial delivery. ICON’s whitepaper explores how evolving Clinical Research Associate roles are improving efficiency, oversight and site engagement. Read more: https://lnkd.in/eJcZvnkV

Latest issue out now. Keep up to date on the latest changes with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribers who have discovered the convenience of this free monthly publication by signing u...

Latest issue out now. Keep up to date on the latest changes in the world of pharma, biotech and medical device clinical trial regulation with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribers who...

Wearables, connected devices, and digital biomarkers are changing how we measure outcomes. When paired with COAs, they offer a richer view of treatment impact. The future of obesity trials lies in this integrated approa...

Day one at #ISPOREurope in Glasgow is coming to a close, and we want to extend our sincere thanks to everyone who visited our booth today. It has been a pleasure connecting and discussing how we can support your goals in...

Attending AASLD 2025? Stop by booth \#1041 to meeting our experts and learn how our deep expertise in imaging-based hepatic biomarkers and global operational support help sponsors optimise trial design and accelerate the...

At Citeline’s recent panel, ICON’s Victoria DeVeaugh-Geiss explored how sponsors can embed smarter risk strategies from protocol design through execution. From AI-driven insights to cross-functional alignment, this blog ...

At Citeline’s recent panel, ICON’s Victoria DeVeaugh-Geiss explored how sponsors can embed smarter risk strategies from protocol design through execution. From AI-driven insights to cross-functional alignment, this blog ...